Abstract
Silicon-substituted hydroxylapatite was prepared to produce a biomaterial with improved bioactivity via aliovalent anion substitution, which leads to the instability of apatite Ca5(PO4)3OH at T > 900 °C and to the formation of a Ca3(PO4)2 phase.
References
1.
Hench L.L.
Journal of the American Ceramic Society,
2005
2.
Kim S.
Biomaterials,
2003
3.
10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
4.
Patel N., Best S.M., Bonfield W., Gibson I.R., Hing K.A., Damien E., Revell P.A.
Journal of Materials Science: Materials in Medicine,
2002
5.
Sayer M., Stratilatov A.D., Reid J., Calderin L., Stott M.J., Yin X., MacKenzie M., Smith T.J., Hendry J.A., Langstaff S.D.
Biomaterials,
2003
6.
10.1070/MC2004v014n04ABEH001975_bib6
Lazoryak
Kristallografiya,
1988